Rapid whole genome sequencing methods for RNA viruses.

MinION nanopore device RNA virus next-generation sequencing – NGS rapid amplification of cDNA ends (RACE) rolling circle amplification (RCA) whole genome sequencing (WGS)

Journal

Frontiers in microbiology
ISSN: 1664-302X
Titre abrégé: Front Microbiol
Pays: Switzerland
ID NLM: 101548977

Informations de publication

Date de publication:
2023
Historique:
received: 04 01 2023
accepted: 06 02 2023
entrez: 13 3 2023
pubmed: 14 3 2023
medline: 14 3 2023
Statut: epublish

Résumé

RNA viruses are the etiological agents of many infectious diseases. Since RNA viruses are error-prone during genome replication, rapid, accurate and economical whole RNA viral genome sequence determination is highly demanded. Next-generation sequencing (NGS) techniques perform whole viral genome sequencing due to their high-throughput sequencing capacity. However, the NGS techniques involve a significant burden for sample preparation. Since to generate complete viral genome coverage, genomic nucleic acid enrichment is required by reverse transcription PCR using virus-specific primers or by viral particle concentration. Furthermore, conventional NGS techniques cannot determine the 5' and 3' terminal sequences of the RNA viral genome. Therefore, the terminal sequences are determined one by one using rapid amplification of cDNA ends (RACE). However, since some RNA viruses have segmented genomes, the burden of the determination using RACE is proportional to the number of segments. To date, there is only one study attempting whole genome sequencing of multiple RNA viruses without using above mentioned methods, but the generated sequences' accuracy compared to the reference sequences was up to 97% and did not reach 100% due to the low read depth. Hence, we established novel methods, named PCR-NGS and RCA-NGS, that were optimized for an NGS machine, MinION. These methods do not require nucleic acid amplification with virus-specific PCR primers, physical viral particle enrichment, and RACE. These methods enable whole RNA viral genome sequencing by combining the following techniques: (1) removal of unwanted DNA and RNA other than the RNA viral genome by nuclease treatment; (2) the terminal of viral genome sequence determination by barcoded linkers ligation; (3) amplification of the viral genomic cDNA using ligated linker sequences-specific PCR or an isothermal DNA amplification technique, such as rolling circle amplification (RCA). The established method was evaluated using isolated RNA viruses with single-stranded, double-stranded, positive-stranded, negative-stranded, non-segmented or multi-segmented genomes. As a result, all the viral genome sequences could be determined with 100% accuracy, and these mean read depths were greater than 2,500×, at least using either of the methods. This method should allow for easy and economical determination of accurate RNA viral genomes.

Identifiants

pubmed: 36910229
doi: 10.3389/fmicb.2023.1137086
pmc: PMC9995502
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1137086

Informations de copyright

Copyright © 2023 Misu, Yoshikawa, Sugimoto, Takamatsu, Kurosu, Ouji, Yoshikawa, Shimojima, Ebihara and Saijo.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

J Infect Dis. 2014 Mar;209(6):816-27
pubmed: 24231186
J Virol. 2013 Jan;87(2):1105-14
pubmed: 23135729
Proc Natl Acad Sci U S A. 2020 Mar 31;117(13):7001-7003
pubmed: 32165541
J Virol. 2008 Jan;82(1):311-20
pubmed: 17942560
Database (Oxford). 2018 Jan 1;2018:
pubmed: 29688385
J Virol. 2003 Sep;77(18):9943-50
pubmed: 12941904
Gigascience. 2019 Feb 1;8(2):
pubmed: 30689855
BMC Mol Biol. 2008 Sep 04;9:77
pubmed: 18771595
Cell Mol Life Sci. 2016 Dec;73(23):4433-4448
pubmed: 27392606
Biol Direct. 2018 Apr 20;13(1):6
pubmed: 29678199
Genome Biol. 2018 Jul 13;19(1):90
pubmed: 30005597
Biomol Detect Quantif. 2015 Mar;3:1-8
pubmed: 26753127
Genome Biol. 2016 Nov 25;17(1):239
pubmed: 27887629
Bioinformatics. 2018 Dec 1;34(23):4121-4123
pubmed: 29790939
Euro Surveill. 2017 Mar 30;22(13):
pubmed: 28382917
ILAR J. 2017 Dec 15;58(3):343-358
pubmed: 28985316
Front Microbiol. 2019 Feb 25;10:260
pubmed: 30858830
Nat Commun. 2020 Dec 9;11(1):6272
pubmed: 33298935
Nat Protoc. 2009;4(4):470-83
pubmed: 19300441
Viruses. 2020 Aug 16;12(8):
pubmed: 32824338
Bioinformatics. 2009 Aug 15;25(16):2078-9
pubmed: 19505943
J Virol. 2010 Oct;84(19):9733-48
pubmed: 20660197

Auteurs

Masayasu Misu (M)

Department of Virology I, National Institute of Infectious Diseases, Tokyo, Japan.
Department of Pathogen, Infection and Immunity, Nara Medical University, Nara, Japan.

Tomoki Yoshikawa (T)

Department of Virology I, National Institute of Infectious Diseases, Tokyo, Japan.

Satoko Sugimoto (S)

Department of Virology I, National Institute of Infectious Diseases, Tokyo, Japan.

Yuki Takamatsu (Y)

Department of Virology I, National Institute of Infectious Diseases, Tokyo, Japan.

Takeshi Kurosu (T)

Department of Virology I, National Institute of Infectious Diseases, Tokyo, Japan.

Yukiteru Ouji (Y)

Department of Pathogen, Infection and Immunity, Nara Medical University, Nara, Japan.

Masahide Yoshikawa (M)

Department of Pathogen, Infection and Immunity, Nara Medical University, Nara, Japan.

Masayuki Shimojima (M)

Department of Virology I, National Institute of Infectious Diseases, Tokyo, Japan.

Hideki Ebihara (H)

Department of Virology I, National Institute of Infectious Diseases, Tokyo, Japan.

Masayuki Saijo (M)

Department of Virology I, National Institute of Infectious Diseases, Tokyo, Japan.

Classifications MeSH